X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    $2 Million Gene Therapy Might Become The Standard In The US

    $2 Million Gene Therapy Might Become The Standard In The US

    Cancer Medicine Prices Jump 53% In Five Years In The U.S

    Food And Drug Administration User Fee Has Been Reauthorized

    Cancer Clinical Trials Get A Brand New Platform In Melbourne

    Report Indicates UK £62bn Behind In Global R&D Investment

    Wall Street Cautiously Optimistic After Gene Therapy Deals

    RoboCap: A Robotic Capsule to Improve Gut Drug Delivery

    Once More, M&As In Biotechechnology Industry Are Thriving

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    $2 Million Gene Therapy Might Become The Standard In The US

    $2 Million Gene Therapy Might Become The Standard In The US

    Cancer Medicine Prices Jump 53% In Five Years In The U.S

    Food And Drug Administration User Fee Has Been Reauthorized

    Cancer Clinical Trials Get A Brand New Platform In Melbourne

    Report Indicates UK £62bn Behind In Global R&D Investment

    Wall Street Cautiously Optimistic After Gene Therapy Deals

    RoboCap: A Robotic Capsule to Improve Gut Drug Delivery

    Once More, M&As In Biotechechnology Industry Are Thriving

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home News

COPD Teams Up With Ena On Antiviral Nasal Spray For COVID

Content Team by Content Team
1st March 2022
in News
Glenmark and SaNOtize to commercialize Nitric Oxide Nasal Spray for COVID-19 treatment in India and other Asian markets

The Chronic Obstructive Pulmonary Disease Foundation, or COPD, has stepped forward to help Ena Respiratory, an Australian clinical-stage pharma company, to develop an antiviral nasal spray targeting chronic lung disease patients. Ena is getting ready to conduct phase 2 tests to see if the nasal spray will prevent COVID-19 as well as influenza.

Ena raised roughly $24 million last summer to fund a phase 1 trial of TLR2/6 agonist INNA-051. It hopes to help people fight viruses like SARS-CoV-2 as well as influenza by upregulating innate immunity in their airway epithelial cells by delivering the molecule to the nose. The COPD Foundation, a non-profit organisation, became aware of INNA-051 for its mechanism of action.

The COPD Foundation’s chief scientific officer, Ruth Tal-Singer, Ph.D., said in a statement that today, more than ever, our patient community studies found an urgent need for treatments that avert flare-ups caused by viral infections. The rapidly acting nasal spray may be given before or immediately after viral exposure to aid the body’s response quickly and lessen the likelihood of consequences. The Foundation will collaborate with Ena to manufacture INNA-051 for its use in people suffering from chronic lung disorders, including COPD. Ena landed the deal after putting its nasal spray through a phase 1 study, with more results expected later this year and also focusing on mid-phase research.

INNA-051 will be tested in a randomised COVID-19 post-exposure antiviral prophylaxis research as well as an influenza challenge pre-exposure prophylaxis study, according to Ena. INNA-051 could reduce the occurrence and severity of infections with a variety of respiratory pathogens since it works by increasing the immune response rather than directly attacking the virus.

From the perspective of COPD, a decrease in the incidence and severity of infections could confront a driver of symptom deterioration, prompting the foundation to lend its network of accredited centres, expertise, and patient researchers to the development of INNA-051.

Previous Post

Study derives Rogue antibodies linked to COVID-19 clotting

Next Post

CTI Biopharma's Bone Marrow Cancer Drug Stands FDA Approved

Related Posts

First Virtual Drug Study Tests 2 Likely Alzheimer Therapies
Clinical Trials

First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

7th November 2022
Facilities & Operation

CPhI Pharma Index Shows Unprecedented Global Pharma Optimism

5th November 2022
$2 Million Gene Therapy Might Become The Standard In The US
Drug Development

$2 Million Gene Therapy Might Become The Standard In The US

5th November 2022
News

Cancer Medicine Prices Jump 53% In Five Years In The U.S

3rd November 2022
FDA Approvals

Food And Drug Administration User Fee Has Been Reauthorized

3rd November 2022
Clinical Trials

Cancer Clinical Trials Get A Brand New Platform In Melbourne

3rd November 2022
Next Post
Sandoz Completes Acquisition of Aspens Japanese Operations

CTI Biopharma's Bone Marrow Cancer Drug Stands FDA Approved

Latest News

First Virtual Drug Study Tests 2 Likely Alzheimer Therapies
Clinical Trials

First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

7th November 2022
Facilities & Operation

CPhI Pharma Index Shows Unprecedented Global Pharma Optimism

5th November 2022
$2 Million Gene Therapy Might Become The Standard In The US
Drug Development

$2 Million Gene Therapy Might Become The Standard In The US

5th November 2022
News

Cancer Medicine Prices Jump 53% In Five Years In The U.S

3rd November 2022
FDA Approvals

Food And Drug Administration User Fee Has Been Reauthorized

3rd November 2022
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In